Contact Us

Thank you for visiting Avery Therapeutics. We are happy to answer your questions about our company and our technologies. For more information, please fill out the form below and a representative from Avery Therapeutics will be in touch with you shortly.

 

Thank you for getting in touch! We'll respond soon.

Groundbreaking

 

MyCardia™ is engineered using induced pluripotent stem cells (iPSCs), which were recognized with the Nobel Prize in Physiology or Medicine (2012).

Synergistic

 

MyCardia™ behaves like cardiac tissue and mimics key molecular attributes of the heart. MyCardia™ is comprised of multiple cell types. Each provides a unique therapeutic role that synergistically repairs the heart.

Biologically Active

 

MyCardia™ is the future of regenerative medicine for the heart. MyCardia™ stimulates the body's repair mechanisms to grow new blood vessels and results in development of new cardiac tissue in treated areas.